$POAI Predictive Oncology Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Predictive Oncology Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Predictive Oncology Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Predictive Oncology Inc. for free.
IRS Number: 331007393
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Trading Symbol: POAI
Company Address: 2915 COMMERS DRIVE, SUITE 900 EAGAN 55121
Phone number: 651-389-4800
Former name: BioDrain Medical, Inc., date of change: 2008-09-25
Former name: Precision Therapeutic Inc., date of change: 2018-02-08
Former name: Skyline Medical Inc., date of change: 2013-08-07
Former name: Precision Therapeutics Inc., date of change: 2018-03-14
Market Capitalization: $8.29M
Prev close: $2.16
Average Daily Volume: 1,105,200
Days Low: $2.08
Year Low: $0.08
Year High: $6.05
Predictive Oncology Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | POAI | Predictive Oncolog ... | Jenkins Christina Lee MD | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Apr 02 2021 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Grant | A | 0.00 | 4,959 | 0 | 9,657 | 4.7 K to 9.7 K (+105.56 %) |
| Apr 02 2021 | POAI | Predictive Oncolog ... | HANDLEY DANIEL E | Director | Grant | A | 0.00 | 4,959 | 0 | 9,029 | 4.1 K to 9 K (+121.84 %) |
| Apr 02 2021 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | CEO and Chairman | Grant | A | 0.00 | 4,959 | 0 | 9,029 | 4.1 K to 9 K (+121.84 %) |
| Apr 02 2021 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Grant | A | 0.00 | 4,959 | 0 | 17,029 | 12.1 K to 17 K (+41.09 %) |
| Apr 02 2021 | POAI | Predictive Oncolog ... | ST. CLAIR GREGORY SR | Director | Grant | A | 0.00 | 6,887 | 0 | 11,585 | 4.7 K to 11.6 K (+146.59 %) |
| Apr 02 2021 | POAI | Predictive Oncolog ... | Nuzum Charles Lee Sr | Director | Grant | A | 0.00 | 6,887 | 0 | 13,599 | 6.7 K to 13.6 K (+102.61 %) |
| Mar 12 2021 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Buy | J | 1.43 | 100,401 | 143,573 | 1,711,742 | 1.6 M to 1.7 M (+6.23 %) |
| Jan 05 2021 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.73 | 47,788 | 35,000 | 47,788 | |
| Jan 05 2021 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Option Exercise | A | 0.73 | 34,135 | 25,000 | 34,135 | |
| Jan 05 2021 | POAI | Predictive Oncolog ... | HANDLEY DANIEL E | Director | Option Exercise | A | 0.73 | 20,481 | 15,000 | 20,481 | |
| Oct 26 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Sell | S | 0.85 | 640 | 544 | 1,611,341 | 1.6 M to 1.6 M (-0.04 %) |
| Oct 26 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Sell | S | 0.85 | 640 | 544 | 1,611,341 | 1.6 M to 1.6 M (-0.04 %) |
| Oct 02 2020 | POAI | Predictive Oncolog ... | ENGLE J MELVILLE | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
| Oct 02 2020 | POAI | Predictive Oncolog ... | CHUNG-WELCH NANCY | Director | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 |